Delfarma

What Delfarma does

Delfarma Sp. z o.o. is a Łódź-headquartered pharmaceutical wholesaler founded in 2004 that operates as the pioneer and self-described leader of parallel import of medicines in Poland. The company sources medicinal products from wholesalers and manufacturers across 22 EU countries where prices are lower, repackages and labels them for the Polish market under 1,300+ active parallel-import permits, and distributes them through three B2B channels: community pharmacies (reaching ~4,300 regular recipients), public hospitals via a dedicated tender department active since 2008 (~200 hospitals), and pharmaceutical wholesalers. Its portfolio spans more than 800 SKUs across OTC, prescription, and reimbursed medicines, sold at 12–40% discounts versus traditional distribution channels, generating an estimated 100 million PLN in annual savings for the Polish healthcare system.

The company operates a vertically integrated physical infrastructure: a 1,800 sq.m. temperature- and humidity-controlled high-bay warehouse (1,600 pallet units, 10m height, with +2°C to +8°C cold-chain capacity), an in-house repackaging facility producing ~55,000 packages per day, and serialization compliant with the EU Falsified Medicines Directive (2D Data Matrix, unique identifiers, anti-tamper devices). It holds ISO 9001:2015 (TÜV SÜD), GMP, GDP, and EAEPC audit certifications. Beyond parallel distribution, Delfarma sells third-party repackaging, warehousing, and storage as fee-for-service lines, and since 2019 has begun launching own-label hospital generics and a seven-brand consumer OTC portfolio (OptiDel Clean, Optidel Jęczmień, Hyaloko, Euphrasia Świetlik, Dr.YGLO, SkinScabin, Kidsner Coco).

Revenue mechanics are transaction-based B2B wholesale margins on parallel-imported products, supplemented by service fees for repackaging and warehousing. Pricing is B2B-driven with a 700 PLN net minimum logistic order per delivery point and ~3-day delivery. The company is privately held under Polish law (Sp. z o.o., registered share capital 250,000 PLN), employs ~200 people (2023), and shows no disclosed venture or institutional ownership, M&A, or external funding activity.

Name

Delfarma

Legal name

Delfarma Sp. z o.o.

Website

https://delfarma.pl

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Delfarma is the leading Polish parallel importer of pharmaceuticals, sourcing medicines from 22 EU countries and selling them to pharmacies, hospitals, and wholesalers at 12–40% below traditional distribution prices, supported by in-house warehousing and repackaging operations.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Parallel Import/Export & Secondary Market Pharmaceutical Wholesalers (HLAIAJAK)

akta.pro secondary industries

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF), Pharmacy Logistics, Returns, Reverse Distribution & Compliance Services (CRAOAHAJ), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical wholesale
• Parallel import
• Medicine distribution
• Pharmaceutical repackaging
• Cold chain logistics

Headquarters

HQ city

Lodz

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Parallel Imported Pharmaceutical Products: Delfarma generates revenue by purchasing medicines in EU countries where prices are lower and selling them in Poland at competitive prices. The company offers products 12-40% cheaper than traditional distribution, serving pharmacies, hospitals, and wholesalers with over 800 pharmaceutical products including OTC, prescription, and reimbursed medicines.
2. Repackaging Services: Third-party and own repackaging services for medicinal products, medical devices, dietary supplements, and cosmetics. Services include batch release, labeling, serialization, and customized packaging solutions.
3. Warehousing and Storage Services: Comprehensive warehousing services including pallet, carton, and unit completion, short and long-term storage, transshipment operations, and temperature-controlled storage for pharmaceutical products.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Delfarma is a pharmaceutical wholesaler specializing in parallel import of medicines within the European Economic Area, purchasing medicines in EU countries where prices are lower and reselling them in Poland at 12-40% lower prices than traditional distribution channels. The company serves pharmacies, hospitals, and wholesalers with over 800 medicinal products, complemented by in-house temperature-controlled warehousing, EU-FMD-compliant serialization, repackaging services, and a portfolio of own-brand consumer health products.

Product overview

Delfarma is a pharmaceutical wholesaler specializing in parallel import of medicines within the European Economic Area, offering over 800 medicinal products including OTC, prescription, and reimbursed medicines at 10-40% lower prices than traditional distribution. The company operates own warehousing (1,600 pallet units) and repackaging facilities providing services for medicines, medical devices, dietary supplements, and cosmetics. Delfarma's proprietary brands include seven consumer health products: OptiDel Clean (sterile eye wipes), Optidel Jęczmień (eyelid ointment), Hyaloko (eye drops with hyaluronic acid), Euphrasia Świetlik (herbal eye drops), Dr. Yglo (wart cryotherapy), SkinScabin (scabies treatment), and Kidsner Coco (cooling foam for chickenpox). Services are offered to pharmacies, hospitals, wholesalers, and patients throughout Poland.

Differentiator

Problem solved

Functional benefit

Brands

• OptiDel: Eyelid and eye area care products including sterile wipes and barley ointment
• Dr.YGLO
• Euphrasia Świetlik Delfarma
• Hyaloko Delfarma
• SkinScabin
• Kidsner Coco

Products and services

• Parallel-imported pharmaceutical products

Quantifiable outcome

• Medicines sold at 12-40% lower prices compared to traditional distribution channels
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• EAEPC (European Association of Euro-Pharmaceutical Companies)coreOthersEuropean Association of Euro-Pharmaceutical Companies membership. Delfarma is an active participant working on removing competition distortions such as dual pricing or quotas at both national and European levels.
• SIRPL (Stowarzyszenie Importu Równoległego Produktów Leczniczych)coreOthersNational parallel import association in Poland. Delfarma is a member working on industry advocacy and regulatory matters related to parallel import.
• EU WholesalerscoreChannel Partner/ Reseller/ DistributorPartnership with wholesalers across EU countries. All partners hold valid wholesaler licenses and quality systems in accordance with GDP guidelines. Suppliers are regularly audited by local authorities.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• 2care4: Danish parallel importer of pharmaceuticals, operating own repackaging and a multi-country EU sourcing model comparable to Delfarma's core activity.
• CC Pharma GmbH: German-based parallel importer of pharmaceuticals supplying pharmacies and wholesalers across the EU; comparable sourcing, repackaging and wholesale model.
• Orifarm Group: Denmark-headquartered, Europe's largest parallel pharmaceutical distributor with parallel import, repackaging and own-brand activities — the closest business-model analogue to Delfarma on a European scale.
• Forfarm Sp. z o.o. Polish pharmaceutical wholesaler and importer, parallel importer like Delfarma, competing in the same Polish hospital tender and pharmacy distribution channels.
• Pharma-Zentrale GmbH: German pharmaceutical wholesaler and parallel importer serving EU markets; comparable EU-wide parallel distribution activity and GDP-compliant operations.
• Euro-Pharma Polska: Polish pharmaceutical wholesaler active in parallel import and pharmacy supply, competing head-to-head with Delfarma for Polish hospital tenders and pharmacy accounts.
• Abcur AB: Swedish parallel importer and pharmaceutical wholesaler with EU-wide parallel import permits and repackaging — direct competitor in the parallel distribution value chain.

Broad incumbents

• Phoenix Group: One of Europe's largest pharmaceutical distribution groups, active across the full wholesale value chain including parallel import — an incumbent peer serving overlapping pharmacy and hospital customers.
• Alliance Healthcare: Pan-European pharmaceutical wholesaler and pre-wholesaler, providing parallel import and full-line distribution to pharmacies and hospitals — broader portfolio than Delfarma but overlapping customer base.
• AAH Pharmaceuticals: UK's largest pharmaceutical wholesaler (part of Walgreens Boots Alliance), distributing branded, generic and parallel-import medicines to pharmacies and hospitals — a much broader incumbent operating comparable distribution lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights8 records

Customer concentration

• LinkedInlinkedin.com/company/delfarma-sp.-z-o.o.

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Delfarma